Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesClinical Application of Cordyceps sinensis on Immunosuppressive Therapy in Renal Transplantation
Transplantation Proceedings, 06/25/09
Li Y et al. - The use of CS may allow decreased dosages and concentrations of CsA causing fewer side effects without an increased risk of acute rejection. In addition, CS with reduced dose CsA may decrease proteinuria and retard CAN progression.
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/23/09
Mycophenolate Mofetil Reduces Late Renal Allograft Loss Independent of Acute Rejection
Transplantation, 10/29/09
T Cell–Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective
Clinical Cancer Research, 10/26/09
Today in Surgery/Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Antibody-mediated rejection following transplantation from an HLA-identical sibling
Nephrology Dialysis Transplantation, 10/30/09
Mycophenolate Mofetil Reduces Late Renal Allograft Loss Independent of Acute Rejection
Transplantation, 10/29/09
ABO-Incompatible Kidney Transplantation
Transplantation, 10/29/09
Sponsor
Article Search
Sponsor